Compositions useful in the diagnostic of latently infected Mycobacterium tuberculosis
US10067147B2 · kind B2 · utility
1Cited by
0References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 28, 2015 |
| Grant date | Sep 4, 2018 |
| Priority date | — |
| Expiry date | Aug 28, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/57
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention concerns a composition comprising at least three peptides derived from Mycobacterium tuberculosis antigen Rv2626c, its use in the diagnostic of latently infected Mycobacterium tuberculosis (LTBI) subjects, corresponding methods of use and kits.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.